الفهرس 
Table of contentsOnly 14 pages are availabe for public view
 |  | from | 103 |  |  |
| | | from | 103 | | |
Abstract
Finally, we can summarize our study in the use of systemic lidocaine infusion at rate 1mg/kg/h in adult obese patients with BMI ranging from 40kg/m2 to 60kg/m2 undergoing laparoscopic bariatric surgery is associated with stable perioperative hemodynamics, decreased pain intensity in the first postoperative 24 h, reduced postoperative opioid requirements, early bowel movement, passing flatus and mobilization, short time ICU and hospital stay with minimal risk of serious complications such as lidocaine toxicity. Aim of the work. This study evaluated the postoperative analgesic efficacy and quality of recovery of systemic lidocaine in obese patients undergoing laparoscopic bariatric surgery. Study design: This randomized, double-blinded, controlled study was conducted in Mansoura University Hospitals (MUH) from January 2020 to June 2020. It included 42 patients of both genders of the American Society of Anesthesiologists (ASA) physical status I and II scheduled for laparoscopic bariatric surgery. The entire cases were subdivided into two groups, an intravenous lidocaine group (group IL) and placebo group (group P). The current study demonstrated the following results: • Both groups were comparable in terms of gender, age, weight, height, and BMI. • Both groups were comparable in VAS score at rest and on cough at zero hour. • An intravenous lidocaine group showed lowering in VAS score at rest and on cough at 6, 12, 18, and 24h postoperative compared to the placebo group. • Placebo group request morphine earlier than the I.V. lidocaine group. • The placebo group required morphine significantly comparable to the I.V. lidocaine group. • I.V. lidocaine group showed of bowel function regained earlier than the placebo group. • Time for early mobilization, length of ICU and length of hospital stay was shorter in the I.V. lidocaine group than placebo. • Only two patients developed symptoms of lidocaine toxicity in the IL group. Both groups were comparable regarding hemodynamics (mean arterial pressure and heart rate).